Overall Status

Completed (22)

Recruiting (3)

Not yet recruiting (1)

Terminated (1)

Withdrawn (1)

Phase

phase 2 (14)

n/a (6)

phase 1 (4)

phase 1/phase 2 (4)

Sponsor

Fred Hutchinson Cancer Center (21)

National Cancer Institute (NCI) (3)

Academic and Community Cancer Research United (1)

Martin, Paul (1)

Morphotek (1)

University of Washington (1)

Collaborator

National Cancer Institute (NCI) (22)

National Heart, Lung, and Blood Institute (NHLBI) (5)

AstraZeneca (1)

Children's Oncology Group (1)

Mustang Bio (1)

National Institutes of Health (NIH) (1)

Study Documents

Intervention Type

drug (26)

procedure (19)

other (17)

radiation (14)

biological (13)

genetic (2)

Funder Type

Other (24)

NIH (3)

Industry (1)

Study Type

Interventional (28)

Recurrent Small Lymphocytic Lymphoma

Showing NaN - NaN of 28

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Accelerated Phase Chronic Myelogenous Leukemia, Acute Leukemias of Ambiguous Lineage, Acute Myeloid Leukemia/Transient

Completed

Accelerated Phase Chronic Myelogenous Leukemia
+50 more

Akt inhibitor MK2206
+2 more

Birmingham, Alabama
+24 more

Apr 28, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in

Completed

Has Results

Accelerated Phase Chronic Myelogenous Leukemia
+88 more

palifermin
+3 more

Seattle, Washington

Fred Hutchinson Cancer Research Center/University of Washington

Feb 19, 2014

Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic

Completed

Accelerated Phase Chronic Myelogenous Leukemia
+84 more

sunitinib malate
+2 more

Los Angeles, California
+10 more

Mar 14, 2014